Research Progress on Immunization and Targeted Therapy for Triple-negative Breast Cancer

Research Progress on Immunization and Targeted Therapy for Triple-negative Breast Cancer

Triple-negative breast cancer (TNBC) accounts for approximately 15%–20% of all breast cancers. Patients with TNBC have a rapidly progressive clinical course, an earlier age of onset, faster distant recurrence, and more common visceral metastases as compared with other subtypes. However, treatment of...

Full description

Bibliographic Details
Main Authors: SHI Chao, ZHANG Xiangmei, LIU Yunjiang
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2023-07-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
triple-negative breast cancer
immunotherapy
targeted therapy
lag3
Online Access:http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1426

Internet

http://www.zlfzyj.com/EN/10.3971/j.issn.1000-8578.2023.22.1426

Similar Items